Загрузка...
CDK8-Novel Therapeutic Opportunities
Improvements in cancer therapy frequently stem from the development of new small-molecule inhibitors, paralleled by the identification of biomarkers that can predict the treatment response. Recent evidence supports the idea that cyclin-dependent kinase 8 (CDK8) may represent a potential drug target...
Сохранить в:
| Опубликовано в: : | Pharmaceuticals (Basel) |
|---|---|
| Главные авторы: | , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
MDPI
2019
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6630639/ https://ncbi.nlm.nih.gov/pubmed/31248103 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ph12020092 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|